David Miles
Tracked across 1 events · 21 articles · First seen May 29, 2026 · Last active Jun 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Professor David Miles, a leading cancer specialist, described the OPTIMA trial findings as 'practice-changing', emphasizing the significant impact the Prosigna test will have on breast cancer treatment.
May 29, 2026 · 21 articles
ERGEN INTELLIGENCE
Track David Miles live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard